Riddhi Siddhi Gluco Biols Limited, a key player in the Indian corporate landscape, has recently issued a clarification regarding its classification under SEBI's regulatory framework. In a formal communication addressed to the Bombay Stock Exchange (BSE) on April 26, 2025, the company made an important disclosure regarding its standing as a Large Corporate entity. This clarification comes in response to the SEBI Circular SEBI/HO/DDHS-RACP0D1/P/CIR/2023/172 dated October 19, 2023, which pertains to the fund-raising process via debt securities by large corporate entities.

The letter underscores that Riddhi Siddhi Gluco Biols does not qualify as a Large Corporate entity as defined by the SEBI circulars governing the issuance of debt securities. The company’s disclosure outlines the specifics of its financial position, including its borrowing status as of March 31, 2025, confirming that there are no outstanding borrowings under the applicable regulations. Furthermore, the company confirmed that it has not received any credit rating exceeding the CRISIL BBB-, and it remains compliant with the regulatory requirements set forth by SEBI.

In Annexure-A, included with the disclosure, the company has provided a detailed breakdown of its financial standing, including its CIN (Corporate Identification Number), the total outstanding borrowings, and its credit rating during the previous fiscal year. The annexure further clarifies that, as per the regulations, the company will not be required to make any payment to the stock exchanges in case of a shortfall in the prescribed borrowing framework.

Riddhi Siddhi Gluco Biols Limited also reiterates that it is fully aligned with the guidelines set out in the SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, which defines the criteria for determining the classification of entities as Large Corporates. This circular has been instrumental in guiding companies like Riddhi Siddhi Gluco Biols on how to disclose their borrowing requirements and maintain transparency in corporate financial dealings.

The non-applicability of this SEBI circular to the company means that Riddhi Siddhi Gluco Biols is exempt from the specific obligations tied to large corporate entities, particularly in relation to the issuance of debt securities. This exemption further underscores the company's position as a compliant and transparent corporate entity under the regulatory purview of SEBI, contributing to its credibility in the corporate financial markets.

This disclosure and clarification are essential in ensuring that Riddhi Siddhi Gluco Biols Limited continues to meet the regulatory expectations laid out by SEBI, while also providing stakeholders with clarity on its financial standing and obligations. In this regard, the company’s management, including Mr. Sharad Jain, Company Secretary & Compliance Officer, and Mr. Mukeshkumar Samdaria, Chief Financial Officer, have jointly confirmed the accuracy and compliance of this information.

The company’s decision to make this disclosure reflects its commitment to transparency, ensuring that its investors, stakeholders, and the regulatory bodies are kept informed about its operations and financial status in line with evolving industry regulations. It is an important step in maintaining corporate governance standards and reinforcing trust within the financial ecosystem.

Moving forward, Riddhi Siddhi Gluco Biols will continue to monitor changes in SEBI's regulatory framework, ensuring ongoing compliance with the guidelines and providing timely updates as required by the regulatory authorities. This commitment ensures that the company remains a responsible and well-governed entity within the corporate sphere.

The Upcoming IPOs in this week and coming weeks are Ather Energy, Iware Supplychain Services, Arunaya Organics,Kenrik Industries.

The Closed IPOs are Tankup Engineers.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.